Andere Kunden interessierten sich auch für
![Non-Structural Protein (NS1) Profile of Dengue Patients]( "Non-Structural Protein (NS1) Profile of Dengue Patients")
Non-Structural Protein (NS1) Profile of Dengue Patients26,99 €![Approaches to the Inhibition of Class II FBP Aldolase]( "Approaches to the Inhibition of Class II FBP Aldolase")
Approaches to the Inhibition of Class II FBP Aldolase36,99 €![Class 3 Hydrolases]( "Class 3 Hydrolases")
Class 3 Hydrolases255,73 €![Class 3.2 Hydrolases VIII]( "Class 3.2 Hydrolases VIII")
Class 3.2 Hydrolases VIII249,99 €![Class 1 Oxidoreductases]( "Class 1 Oxidoreductases")
Class 1 Oxidoreductases221,99 €![Class 1 Oxidoreductases V]( "Class 1 Oxidoreductases V")
Class 1 Oxidoreductases V249,99 €![Class 3.2 Hydrolases VII]( "Class 3.2 Hydrolases VII")
Class 3.2 Hydrolases VII291,99 €
Despite aggressive efforts in dengue research, the control of dengue diseases and discovery of therapeutics against them await complete elucidation of its complex immune-pathogenesis. Virtually all mammalian cells express surface major histocompatibility complex class I (MHC Class I) molecules which are crucial for immune recognition and MHC-restricted cytolysis as part of the adaptive immune response. In contrast to many viruses that escape this host s immune responses by suppressing the MHC Class I pathway, infections by Flaviviruses, such West Nile virus, have been associated with a virus-specific increase of these antigen-presenting molecules. This study presents evidence of MHC Class I gene modulation by dengue virus, hence providing a better understanding of dengue immunopathogenesis that would consequently facilitate the discovery of antiviral therapeutics against dengue.